These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 23570542)

  • 21. Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects.
    Liao V; Liu T; Codd R
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6200-4. PubMed ID: 22932316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and synthesis of novel isoxazole-based HDAC inhibitors.
    Conti P; Tamborini L; Pinto A; Sola L; Ettari R; Mercurio C; De Micheli C
    Eur J Med Chem; 2010 Sep; 45(9):4331-8. PubMed ID: 20637529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4.
    Lamaa D; Lin HP; Zig L; Bauvais C; Bollot G; Bignon J; Levaique H; Pamlard O; Dubois J; Ouaissi M; Souce M; Kasselouri A; Saller F; Borgel D; Jayat-Vignoles C; Al-Mouhammad H; Feuillard J; Benihoud K; Alami M; Hamze A
    J Med Chem; 2018 Aug; 61(15):6574-6591. PubMed ID: 30004697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agents.
    Oanh DT; Hai HV; Park SH; Kim HJ; Han BW; Kim HS; Hong JT; Han SB; Hue VT; Nam NH
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7509-12. PubMed ID: 22036991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of aryl ether and sulfone hydroxamic acids as potent histone deacetylase (HDAC) inhibitors.
    Pabba C; Gregg BT; Kitchen DB; Chen ZJ; Judkins A
    Bioorg Med Chem Lett; 2011 Jan; 21(1):324-8. PubMed ID: 21109435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, evaluation and molecular modeling of cyclic tetrapeptide histone deacetylase inhibitors as anticancer agents.
    Huang D; Li X; Sun L; Xiu Z; Nishino N
    J Pept Sci; 2012 Apr; 18(4):242-51. PubMed ID: 22253009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Sarver RW; Bills E; Bolton G; Bratton LD; Caspers NL; Dunbar JB; Harris MS; Hutchings RH; Kennedy RM; Larsen SD; Pavlovsky A; Pfefferkorn JA; Bainbridge G
    J Med Chem; 2008 Jul; 51(13):3804-13. PubMed ID: 18540668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel inhibitors of human histone deacetylases: design, synthesis and bioactivity of 3-alkenoylcoumarines.
    Seidel C; Schnekenburger M; Zwergel C; Gaascht F; Mai A; Dicato M; Kirsch G; Valente S; Diederich M
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3797-801. PubMed ID: 25042254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and biological evaluation of indeno[1,2-d]thiazole derivatives as potent histone deacetylase inhibitors.
    Zhou M; Ning C; Liu R; He Y; Yu N
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3200-3. PubMed ID: 23639537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific inhibitions of annonaceous acetogenins on class II 3-hydroxy-3-methylglutaryl coenzyme A reductase from Streptococcus pneumoniae.
    Feng L; Zhou L; Sun Y; Gui J; Wang X; Wu P; Wan J; Ren Y; Qiu S; Wei X; Li J
    Bioorg Med Chem; 2011 Jun; 19(11):3512-9. PubMed ID: 21550257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis for the design and synthesis of selective HDAC inhibitors.
    Di Micco S; Chini MG; Terracciano S; Bruno I; Riccio R; Bifulco G
    Bioorg Med Chem; 2013 Jul; 21(13):3795-807. PubMed ID: 23693069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates.
    Suzuki T; Nagano Y; Kouketsu A; Matsuura A; Maruyama S; Kurotaki M; Nakagawa H; Miyata N
    J Med Chem; 2005 Feb; 48(4):1019-32. PubMed ID: 15715470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Search for novel histone deacetylase inhibitors. Part II: design and synthesis of novel isoferulic acid derivatives.
    Lu W; Wang F; Zhang T; Dong J; Gao H; Su P; Shi Y; Zhang J
    Bioorg Med Chem; 2014 May; 22(9):2707-13. PubMed ID: 24702857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening.
    Zhang QY; Wan J; Xu X; Yang GF; Ren YL; Liu JJ; Wang H; Guo Y
    J Comb Chem; 2007; 9(1):131-8. PubMed ID: 17206841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of 1,10-phenanthroline-based hydroxamate derivative as dual histone deacetylases/ribonucleotide reductase inhibitor with antitumor activities.
    Shetty MG; Pai P; Dey B; Satyamoorthy K; Shil S; Nayak UY; T A; Sundara BK
    Daru; 2024 Jun; 32(1):263-278. PubMed ID: 38683491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of the first histone deacetylase 6/8 dual inhibitors.
    Olson DE; Wagner FF; Kaya T; Gale JP; Aidoud N; Davoine EL; Lazzaro F; Weïwer M; Zhang YL; Holson EB
    J Med Chem; 2013 Jun; 56(11):4816-20. PubMed ID: 23672185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4-N-Hydroxy-4-[1-(sulfonyl)piperidin-4-yl]-butyramides as HDAC inhibitors.
    Rossi C; Fincham CI; D'Andrea P; Porcelloni M; Ettorre A; Mauro S; Bigioni M; Binaschi M; Maggi CA; Nardelli F; Parlani M; Fattori D
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6767-9. PubMed ID: 21978679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Synthesis and activity of some new histone deacetylases inhibitors].
    Cheng YH; Guo YS; Han HZ; Wang N; Zhang GH; Guo ZR; Wu S
    Yao Xue Xue Bao; 2010 Jun; 45(6):735-41. PubMed ID: 20939182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Design, synthesis, and biological activities of histone deacetylase inhibitors with diketo ester as zinc binding group].
    Lu H; Su H; Yang B; You QD
    Yao Xue Xue Bao; 2011 Mar; 46(3):293-8. PubMed ID: 21626783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and docking studies on benzamide derivatives as histone deacetylase inhibitors.
    Lu A; Luo H; Shi M; Wu G; Yuan Y; Liu J; Tang F
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4924-7. PubMed ID: 21741834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.